H-IPLENLQIIR^-OH

Ref. 3D-PP40163

Informations sur le produit

• Nom: H-IPLENLQIIR^-OH
• Synonymes: NH2-Ile-Pro-Leu-Glu-Asn-Leu-Gln-Ile-Ile-Arg^-OH

Description

Peptide H-IPLENLQIIR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-IPLENLQIIR^-OH include the following: Data-independent acquisition mass spectrometry to quantify protein levels in FFPE tumor biopsies for molecular diagnostics YJ Kim, SMM Sweet , JD Egertson - Journal of proteome , 2018 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jproteome.8b00699 Selected reaction monitoring (SRM) analysis of epidermal growth factor receptor (EGFR) in formalin fixed tumor tissue T Hembrough, S Thyparambil, WL Liao, MM Darfler - Clinical proteomics, 2012 - Springerhttps://link.springer.com/article/10.1186/1559-0275-9-5 Label-free quantitation of protein modifications by pseudo selected reaction monitoring with internal reference peptides SD Sherrod , MV Myers, M Li, JS Myers - Journal of proteome , 2012 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/pr201240a The addition of FAIMS increases targeted proteomics sensitivity from FFPE tumor biopsies S Sweet , D Chain, W Yu, P Martin, M Rebelatto - Scientific Reports, 2022 - nature.comhttps://www.nature.com/articles/s41598-022-16358-1 High-Field Asymmetric Waveform Ion Mobility Spectrometry and Parallel Reaction Monitoring Increases Sensitivity for Clinical Biomarker Quantitation from Formalin S Sweet , D Chain, W Yu, P Martin, M Rebelatto - bioRxiv, 2022 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2022.02.08.479554.abstract Regulated Phosphosignaling Associated with Breast Cancer Subtypes and Druggability MM Kinsinger13, H Rodriguez13, MJ Ellis14 - researchgate.nethttps://www.researchgate.net/profile/Mehdi-Mesri/publication/333769448_Regulated_Phosphosignaling_Associated_with_Breast_Cancer_Subtypes_and_Druggability/links/5d3fcca1a6fdcc370a6bce53/Regulated-Phosphosignaling-Associated-with-Breast-Cancer-Subtypes-and-Druggability.pdf Comparative evaluation of strategies for quantifying signaling pathway proteins in Ewing sarcoma MA Applebaum, DG Thomas - Applied , 2014 - journals.lww.comhttps://journals.lww.com/appliedimmunohist/fulltext/2014/09000/Comparative_Evaluation_of_Strategies_for.6.aspx Characterization of MGMT and EGFR protein expression in glioblastoma and association with survival LR Schaff , D Yan, S Thyparambil, Y Tian - Journal of Neuro , 2020 - Springerhttps://link.springer.com/article/10.1007/s11060-019-03358-x Odin (ANKS1A) modulates EGF receptor recycling and stability J Tong, Y Sydorskyy, JR St-Germain, P Taylor - PloS one, 2013 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0064817 Proteomic analysis of the EGFR interactome and post-translational modifications associated with receptor endocytosis in response to EGF and stress J Tong, P Taylor, MF Moran - Mol Cell Proteomics, 2014 - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=5da23653879cecf03e12b96fa0a33eba747a6dc4 Efficient microscale basic reverse phase peptide fractionation for global and targeted proteomics HJ Lee , HJ Kim, DC Liebler - Journal of proteome research, 2016 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jproteome.6b00102 CD166-mediated epidermal growth factor receptor phosphorylation promotes the growth of oral squamous cell carcinoma G Jia, X Wang, M Yan, W Chen, P Zhang - Oral Oncology, 2016 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1368837516300562

• Marque: Biosynth